Match tier
Confirmed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
M
Made Harumi Padmaswari
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Role not yet determined Is this you? Add your title
3 h-index
6 pubs
34 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Made Harumi Padmaswari's research focuses on developing gene editing strategies for Duchenne muscular dystrophy (DMD). Her work investigates the challenges associated with delivering CRISPR-Cas9 genome editing tools to treat this genetic disorder, specifically exploring exon skipping as a therapeutic approach. Padmaswari has published on optimizing recombinant Cas9 expression for enhanced protein purification and genome editing applications. Her research also examines the precision and efficacy of RNA-guided DNA integration in muscle cells and the complex genomic and transcriptomic changes that can occur following AAV-CRISPR therapy for DMD. She collaborates with researchers at the University of Arkansas at Fayetteville, including Christopher E. Nelson and Shilpi Agrawal, and has authored six publications with them.
Metrics
- h-index: 3
- Publications: 6
- Citations: 34
Selected Publications
-
Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy (2025)
-
Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping (2025)
-
Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024)
-
Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing (2024)
-
Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024)
-
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023)
Collaboration Network
Top Collaborators
Shilpi Agrawal
University of Arkansas at Little Rock
6 shared publications
In database
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping
Showing 5 of 6 shared publications
Christopher E. Nelson
University of Arkansas at Little Rock
6 shared publications
In database
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping
Showing 5 of 6 shared publications
Mary S. Jia
University of Arkansas at Little Rock
4 shared publications
In database
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
Gabrielle N. Bulliard
University of Arkansas at Little Rock
3 shared publications
In database
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
Daniel A. Maxenberger
University of Arkansas at Fayetteville
2 shared publications
In database
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
Landon A. Burcham
University of Arkansas at Little Rock
2 shared publications
In database
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
Abbey L. Stokes
University of Arkansas at Little Rock
2 shared publications
In database
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
Allie Ivy
University of Arkansas at Fayetteville
1 shared publication
In database
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
Morgan Reese
University of Arkansas at Fayetteville
1 shared publication
In database
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
Adila Khalil
University of Arkansas at Fayetteville (US)
1 shared publication
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
Sabin Khadgi
University of Arkansas at Fayetteville
1 shared publication
In database
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
Kevin A. Murach
University of Arkansas at Fayetteville
1 shared publication
In database
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
Similar Researchers
Based on overlapping research topics
Gabrielle N. Bulliard
University of Arkansas at Fayetteville
CRISPR and Genetic Engineering
Metabolism and Genetic Disorders
Disease Models, Animal
Allie Ivy
University of Arkansas at Fayetteville
CRISPR and Genetic Engineering
Metabolism and Genetic Disorders
Disease Models, Animal
Christopher E. Nelson
University of Arkansas at Fayetteville
CRISPR and Genetic Engineering
Metabolism and Genetic Disorders
Disease Models, Animal
Aravindhan Veerapandiyan
University of Arkansas for Medical Sciences
Muscular Dystrophy
Genetic Therapy
Metabolism and Genetic Disorders
Amie Donathan
University of Arkansas at Fayetteville
CRISPR and Genetic Engineering
Metabolism and Genetic Disorders
Daniel A. Maxenberger
University of Arkansas at Fayetteville
CRISPR and Genetic Engineering
Metabolism and Genetic Disorders